Safety Evaluations Include: Laboratory Test Abnormalities; BARS and SAS; Physical Examinations; Vital Signs; Electrocardiogram,Etc.
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With Schizophrenia (NCT01260116) | Wuhan University | 2010-12-01 |
Track Safety Evaluations Include: Laboratory Test Abnormalities; BARS and SAS; Physical Examinations; Vital Signs; Electrocardiogram,Etc. automatically
Every clearance here is in the API, with alerts when new ones post.